Donaron-Met Tablet is a combination medicine used to treat diabetic dyslipidaemia (high cholesterol levels in diabetic patients) and poor blood flow. Also, Donaron-Met Tablet may be used to treat the polycystic ovarian syndrome. Diabetic dyslipidaemia is a condition associated with high levels of bad cholesterol (low- density lipoprotein), high triglyceride (a type of fat in the blood) levels and low levels of good cholesterol (high-density lipoprotein) in diabetic patients.
Donaron-Met Tablet is a combination of two drugs, namely: Metformin (antidiabetic) and Inositol nicotinate (vasodilator). Metformin works by reducing the sugar production by cells in the liver and delays sugar absorption from intestines. Also, it increases the sensitivity of muscle cells to insulin which enables these cells to remove sugar more effectively from the blood. Inositol nicotinate works by widening blood vessels and lower cholesterol levels.
Take Donaron-Met Tablet as prescribed by your doctor. You are advised to take Donaron-Met Tablet for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience stomach pain, diarrhoea, nausea, vomiting, and loss of appetite. Most of these side effects of Donaron-Met Tablet do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to Donaron-Met Tablet or any other medicines, please tell your doctor. Donaron-Met Tablet is not recommended for children below 10 years of age, as the safety and effectiveness were not established. Avoid breastfeeding while taking Donaron-Met Tablet and consult a doctor. If you are pregnant or planning for pregnancy, please inform your doctor before taking Donaron-Met Tablet . Avoid alcohol consumption with Donaron-Met Tablet as it may increase the risk of a life-threatening condition known as lactic acidosis. Drive only if you are alert as Donaron-Met Tablet may cause dizziness, weakness or decrease alertness.